Atlas Trials

Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment

Clinical trial NCT01072812 · TERMINATED

Trial details

NCT number
NCT01072812
Sponsor
Annovis Bio Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer's DiseaseAmnestic Mild Cognitive Impairment
Start date
2010-02-01
Primary completion
2010-07-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.